Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms
Cancers · 24.06.2026 · 18 (13) · 2052
DOI: 10.3390/cancers18132052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 24.06.2026. Verfasst von Velizar Shivarov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Research, Medical University Pleven, 5800 Pleven, Bulgaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund (Bulgaria).
Abstract (Originalsprache)
Background/Objectives: Immune surveillance is increasingly recognized as a modifier of myeloproliferative neoplasm (MPN) initiation and evolution, yet the contribution of the NKG2D receptor and its ligands MICA/MICB to CALR-mutated disease remains unclear.
Methods
We performed high-resolution next-generation sequencing genotyping of MICA and MICB in 43 patients with CALR-mutated MPN (WHO 2022 criteria) and compared the allele and haplotype distributions with those of 156 healthy Bulgarian controls and 85 patients with JAK2 V617F-positive MPN. Associations were tested using age- and sex-adjusted additive generalized linear models; bi-locus haplotypes were evaluated using haplotype score methods. In a genotyped subgroup (35 CALR-mutated MPN patients and 105 controls), functional KLRK1 (NKG2D) polymorphisms were analyzed for haplotype-level associations. We also performed 700 ns molecular dynamics simulations of selected MICA variants in complex with NKG2D and reanalyzed publicly available single-cell RNA-sequencing data (GSE117826) and RNA-sequencing data from CRISPR/Cas9-edited CALR-mutant iPSC-derived megakaryocytes to evaluate MICA/MICB expression.
Results
MICA*004:001 was significantly associated with CALR-mutated MPN versus controls (p = 0.004; Bonferroni-adjusted p = 0.047), while MICB*008:001 showed only nominal association. Exploratory haplotype analyses identified a MICA*009:01-MICB*004:001 haplotype associated with CALR-mutated status (p = 0.008) and a KLRK1 G-A-G-T haplotype (rs1049174-rs2617160-rs2246809-rs2617170) associated with increased CALR-mutated MPN risk (OR = 3.61; p = 0.029). Transcriptomic reanalysis indicated a higher fraction of CALR-mutant stem and progenitor cells expressing detectable MICA/MICB transcripts, and heterozygous CALR-mutant megakaryocytes exhibited higher MICA expression than the wild type.
Conclusions
Together, these data support an exploratory immunogenetic and transcriptomic link between the NKG2D-MICA/MICB axis and CALR-mutated MPN, but direct protein-level and functional studies are required before mechanistic or therapeutic conclusions can be drawn.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Research, Medical University Pleven, 5800 Pleven, Bulgaria.
- Department of Clinical Hematology, St. Sophia General Hospital, 1618 Sofia, Bulgaria.
- Department of Clinical Hematology, Alexandrovska University Hospital, Medical University Sofia, 1431 Sofia, Bulgaria.
- Department of Clinical Hematology, Saint Marina University Hospital, Medical University Varna, 9010 Varna, Bulgaria.
- Department of Physical Chemistry, Faculty of Chemistry and Pharmacy, Sofia University "St. Kl. Ohridski", 1164 Sofia, Bulgaria.
- Department of Clinical Immunology, Alexandrovska University Hospital, Medical University Sofia, 1431 Sofia, Bulgaria.
ORCID-Profile: Velizar Shivarov, Galia Madjarova, Milena Ivanova
Förderung
- National Science Fund (Bulgaria)
Zitieren
APA
Shivarov, V., Tsvetkova, G., Micheva, I., Hadjiev, E., Petkova, J., Madjarova, G., & Ivanova, M. (2026). Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms. Cancers, 18(13), 2052. https://doi.org/10.3390/cancers18132052
Vancouver
Shivarov V, Tsvetkova G, Micheva I, Hadjiev E, Petkova J, Madjarova G, et al. Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms. Cancers. 2026;18(13):2052. doi:10.3390/cancers18132052
BibTeX
@article{Shivarov2026,
author = {Shivarov, Velizar and Tsvetkova, Gergana and Micheva, Ilina and Hadjiev, Evgueniy and Petkova, Jasmina and Madjarova, Galia and Ivanova, Milena},
title = {Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms},
journal = {Cancers},
year = {2026},
volume = {18},
number = {13},
pages = {2052},
doi = {10.3390/cancers18132052}
}
EUVIMED